edaravone and imm-h004
edaravone has been researched along with imm-h004 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, N; Hu, J; Kong, L; Liu, G; Song, X; Sun, M; Sun, Y; Wang, D; Wang, Y; Wu, D | 1 |
Chen, NH; Han, N; Zhang, W; Zuo, W | 1 |
Other Studies
2 other study(ies) available for edaravone and imm-h004
Article | Year |
---|---|
Coumarin derivatives protect against ischemic brain injury in rats.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Coumarins; Male; Molecular Structure; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2013 |
Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
Topics: Animals; Antipyrine; bcl-2-Associated X Protein; Brain Ischemia; CA1 Region, Hippocampal; Caspase 3; Cell Death; Coumarins; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Edaravone; Free Radical Scavengers; Intracellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maze Learning; Membrane Proteins; Neurons; Neuroprotective Agents; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Spatial Memory; Synapsins | 2015 |